Primary Record
Levonadifloxacin
- In stock
- 3,981 g
- Purity
- 99.2 %
- CAS
- 154357-42-3
Compound Identifiers & Properties
- CAS
- 154357-42-3
- PubChem CID
- 9850038
- SMILES
- C[C@H]1CCC2=C3N1C=C(C(=O)C3=CC(=C2N4CCC(CC4)O)F)C(=O)O
- Canonical SMILES
- C[C@H]1CCc2c(N3CCC(O)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23
Names & Synonyms
- Levonadifloxacin
- (S)-(-)-Nadifloxacin
- nadifloxacin
- levonadifloxacine
- (S)-nadifloxacin
- levonadifloxacino
- Levonadifloxacina
- levonadifloxacinum
- Levonadifloxacin [INN]
- 154357-42-3
- WCK771 FREE BASE
- NADIFLOXACIN, (S)-
- Levonadifloxacin (INN)
- starbld0002875
- WCK-771 FREE BASE
- RefChem:924705
- wck-771
- UNII-8WHH66L098
- WCK771
- 8WHH66L098
- SCHEMBL36594
- DTXSID70165599
- CHEMBL187677
- CHEMBL190561
- DTXCID0088090
- SCHEMBL29390463
- C19H21FN2O4
- CHEBI:37908
- CTK0H0569
- GTPL10757
- LEVONADIFLOXACIN [WHO-DD]
- WCK 771
- MFCD09954130
- GLXC-27365
- ZINC603195
- BDBM50475221
- CID9850038
- DA-48828
- HY-14926
- MS-25695
- SY343606
- (S)-(-)-OPC-7251
- J281.731D
- CS-0003639
- NS00098910
- A11894
- D11933
- F82021
- (12S)-7-fluoro-8-(4-hydroxypiperidin-1-yl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid
- (S)-9-Fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid
- 1H,5H-Benzo[ij]quinolizine-2-carboxylicacid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (5S)-
- I14-32987
- Q27117310
- (5S)-9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-2-carboxylic acid
- (S)-9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidyl)-5-methyl-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic Acid
- (12S)-7-fluoro-8-(4-hydroxy-1-piperidyl)-12-methyl-4-oxo-1-azatricyclo[7.3.1.05,13]trideca-2,5,7,9(13)-tetraene-3-carboxylic acid
- (4S)-1-Oxo-4beta-methyl-5,6-dihydro-7-(4-hydroxypiperidino)-8-fluoro-4H-3a-aza-1H-phenalene-2-carboxylic acid
- (5S)-9-Fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid
- (5S)-9-Fluoro-6,7-dihydro-8-(4-hydroxypiperidino)-5-methyl-1-oxo-1H,5H-benzo[ij]quinolizine-2-carboxylic acid
- (5S)-9-FLUORO-8-(4-HYDROXYPIPERIDIN-1-YL)-5-METHYL-1-OXO-6,7-DIHYDRO-1H,5H-BENZO(IJ)QUINOLIZINE-2-CARBOXYLIC ACID
- (5S)-9-fluoro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-6,7-dihydro-1H,5H-pyrido[3,2,1-ij]quinolizine-2-carboxylic acid
- (S)-(-)-Nadifloxacin; 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (5S)-; 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (S)-; (5S)-9-Fluoro-6,7-
- 124858-35-1
- 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (5S)-
- 1H,5H-Benzo[ij]quinolizine-2-carboxylic acid, 9-fluoro-6,7-dihydro-8-(4-hydroxy-1-piperidinyl)-5-methyl-1-oxo-, (S)-
- s-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo[i,j]quinolizine-2-carboxylic acid